Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricBDXBecton DickinsonIDXXIdexx LaboratoriesEWEdwards Lifesciences
Snapshot
Price$140.71$545.73$85.88
Market cap$39.67B$44.34B$50.30B
Valuation
P/E35x40.5x45.8x
Forward P/E46.6x32.3x65.5x
Growth
Revenue growth2.4%13.1%13.8%
EPS growth-24.8%25.6%-73.2%
Profitability
Net margin5.3%24.6%17.4%
ROE4.5%70.9%10.6%
Balance sheet & cash
Debt / equity0.76x0.53x0.06x
Free cash flow yield9.0%1.9%2.9%
Dividend yield2.9%——
Verdict
Investment ratingWeak· 37Favorable· 65Neutral· 47

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBDXtoday $141IDXXtoday $546EWtoday $86
2027$107.64 – $157.88+12% CAGR$514.04 – $753.92+38% CAGR$65.70 – $96.36+12% CAGR
2028$109.80 – $161.03+7% CAGR$645.58 – $946.85+32% CAGR$67.01 – $98.28+7% CAGR
2029$111.99 – $164.25+5% CAGR$810.78 – $1,189.15+30% CAGR$68.35 – $100.25+5% CAGR
2030$114.23 – $167.54+4% CAGR$1,018.26 – $1,493.45+29% CAGR$69.72 – $102.26+4% CAGR
2031$116.52 – $170.89+4% CAGR$1,278.83 – $1,875.62+28% CAGR$71.11 – $104.30+4% CAGR
5-yr CAGR-3.7% – 4.0%18.6% – 28.0%-3.7% – 4.0%